<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36768231</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>18</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Diffusion Tensor Imaging in Amyotrophic Lateral Sclerosis: Machine Learning for Biomarker Development.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1911</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24031911</ELocationID><Abstract><AbstractText>Diffusion tensor imaging (DTI) allows the in vivo imaging of pathological white matter alterations, either with unbiased voxel-wise or hypothesis-guided tract-based analysis. Alterations of diffusion metrics are indicative of the cerebral status of patients with amyotrophic lateral sclerosis (ALS) at the individual level. Using machine learning (ML) models to analyze complex and high-dimensional neuroimaging data sets, new opportunities for DTI-based biomarkers in ALS arise. This review aims to summarize how different ML models based on DTI parameters can be used for supervised diagnostic classifications and to provide individualized patient stratification with unsupervised approaches in ALS. To capture the whole spectrum of neuropathological signatures, DTI might be combined with additional modalities, such as structural T1w 3-D MRI in ML models. To further improve the power of ML in ALS and enable the application of deep learning models, standardized DTI protocols and multi-center collaborations are needed to validate multimodal DTI biomarkers. The application of ML models to multiparametric MRI/multimodal DTI-based data sets will enable a detailed assessment of neuropathological signatures in patients with ALS and the development of novel neuroimaging biomarkers that could be used in the clinical workup.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Behler</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7129-7006</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Hans-Peter</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kassubek</LastName><ForeName>Jan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7106-9270</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), 89081 Ulm, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">diffusion tensor imaging</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36768231</ArticleId><ArticleId IdType="pmc">PMC9915541</ArticleId><ArticleId IdType="doi">10.3390/ijms24031911</ArticleId><ArticleId IdType="pii">ijms24031911</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Myszczynska M.A., Ojamies P.N., Lacoste A.M.B., Neil D., Saffari A., Mead R., Hautbergue G.M., Holbrook J.D., Ferraiuolo L. Applications of Machine Learning to Diagnosis and Treatment of Neurodegenerative Diseases. Nat. Rev. Neurol. 2020;16:440&#x2013;456. doi: 10.1038/s41582-020-0377-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0377-8</ArticleId><ArticleId IdType="pubmed">32669685</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., van den Berg L.H. Amyotrophic Lateral Sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Del Tredici K., Toledo J.B., Robinson J.L., Irwin D.J., Grossman M., Suh E., Van Deerlin V.M., Wood E.M., Baek Y., et al. Stages of PTDP-43 Pathology in Amyotrophic Lateral Sclerosis. Ann. Neurol. 2013;74:20&#x2013;38. doi: 10.1002/ana.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23937</ArticleId><ArticleId IdType="pmc">PMC3785076</ArticleId><ArticleId IdType="pubmed">23686809</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., Brettschneider J., Ludolph A.C., Lee V.M., Trojanowski J.Q., Tredici K.D. Amyotrophic Lateral Sclerosis&#x2014;A Model of Corticofugal Axonal Spread. Nat. Rev. Neurol. 2013;9:708&#x2013;714. doi: 10.1038/nrneurol.2013.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman M. Amyotrophic Lateral Sclerosis&#x2014;A Multisystem Neurodegenerative Disorder. Nat. Rev. Neurol. 2019;15:5&#x2013;6. doi: 10.1038/s41582-018-0103-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0103-y</ArticleId><ArticleId IdType="pubmed">30446736</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C., Bonetto V., Pupillo E., Logroscino G., Al-Chalabi A., Lunetta C., Riva N., Mora G., Lauria G., Weishaupt J.H., et al. Focus on the Heterogeneity of Amyotrophic Lateral Sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2020;21:485&#x2013;495. doi: 10.1080/21678421.2020.1779298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1779298</ArticleId><ArticleId IdType="pubmed">32583689</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal N.A., Berry J.D., Windebank A., Staff N.P., Maragakis N.J., Berg L.H., Genge A., Miller R., Baloh R.H., Kern R., et al. Addressing Heterogeneity in Amyotrophic Lateral Sclerosis CLINICAL TRIALS. Muscle Nerve. 2020;62:156&#x2013;166. doi: 10.1002/mus.26801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26801</ArticleId><ArticleId IdType="pmc">PMC7496557</ArticleId><ArticleId IdType="pubmed">31899540</ArticleId></ArticleIdList></Reference><Reference><Citation>Basser P.J. Inferring Microstructural Features and the Physiological State of Tissues from Diffusion-Weighted Images. NMR Biomed. 1995;8:333&#x2013;344. doi: 10.1002/nbm.1940080707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.1940080707</ArticleId><ArticleId IdType="pubmed">8739270</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Bihan D., Mangin J.F., Poupon C., Clark C.A., Pappata S., Molko N., Chabriat H. Diffusion Tensor Imaging: Concepts and Applications. J. Magn. Reason. Imaging. 2001;13:534&#x2013;546. doi: 10.1002/jmri.1076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.1076</ArticleId><ArticleId IdType="pubmed">11276097</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S.-K., Sun S.-W., Ramsbottom M.J., Chang C., Russell J., Cross A.H. Dysmyelination Revealed through MRI as Increased Radial (but Unchanged Axial) Diffusion of Water. Neuroimage. 2002;17:1429&#x2013;1436. doi: 10.1006/nimg.2002.1267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nimg.2002.1267</ArticleId><ArticleId IdType="pubmed">12414282</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J., M&#xfc;ller H.-P., Del Tredici K., Lul&#xe9; D., Gorges M., Braak H., Ludolph A.C. Imaging the Pathoanatomy of Amyotrophic Lateral Sclerosis in Vivo: Targeting a Propagation-Based Biological Marker. J. Neurol. Neurosurg. Psychiatry. 2018;89:374&#x2013;381. doi: 10.1136/jnnp-2017-316365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316365</ArticleId><ArticleId IdType="pmc">PMC5869447</ArticleId><ArticleId IdType="pubmed">29101254</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke R.A.L., Agosta F., Grosskreutz J., Filippi M., Turner M.R. Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2017;14:11&#x2013;23. doi: 10.1007/s13311-016-0484-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-016-0484-9</ArticleId><ArticleId IdType="pmc">PMC5233627</ArticleId><ArticleId IdType="pubmed">27752938</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocar T.D., M&#xfc;ller H.-P., Ludolph A.C., Kassubek J. Feature Selection from Magnetic Resonance Imaging Data in ALS: A Systematic Review. Ther. Adv. Chronic Dis. 2021;12:204062232110510. doi: 10.1177/20406223211051002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223211051002</ArticleId><ArticleId IdType="pmc">PMC8521429</ArticleId><ArticleId IdType="pubmed">34729157</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardenas-Blanco A., Machts J., Acosta-Cabronero J., Kaufmann J., Abdulla S., Kollewe K., Petri S., Heinze H.-J., Dengler R., Vielhaber S., et al. Central White Matter Degeneration in Bulbar- and Limb-Onset Amyotrophic Lateral Sclerosis. J. Neurol. 2014;261:1961&#x2013;1967. doi: 10.1007/s00415-014-7434-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7434-4</ArticleId><ArticleId IdType="pubmed">25059391</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H.-P., Turner M.R., Grosskreutz J., Abrahams S., Bede P., Govind V., Prudlo J., Ludolph A.C., Filippi M., Kassubek J., et al. A Large-Scale Multicentre Cerebral Diffusion Tensor Imaging Study in Amyotrophic Lateral Sclerosis. J. Neurol. Neurosurg. Psychiatry. 2016;87:570&#x2013;579. doi: 10.1136/jnnp-2015-311952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311952</ArticleId><ArticleId IdType="pubmed">26746186</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini N., Douaud G., Mackay C.E., Knight S., Talbot K., Turner M.R. Corpus Callosum Involvement Is a Consistent Feature of Amyotrophic Lateral Sclerosis. Neurology. 2010;75:1645&#x2013;1652. doi: 10.1212/WNL.0b013e3181fb84d1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181fb84d1</ArticleId><ArticleId IdType="pmc">PMC2974368</ArticleId><ArticleId IdType="pubmed">21041787</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardenas-Blanco A., Machts J., Acosta-Cabronero J., Kaufmann J., Abdulla S., Kollewe K., Petri S., Schreiber S., Heinze H.-J., Dengler R., et al. Structural and Diffusion Imaging versus Clinical Assessment to Monitor Amyotrophic Lateral Sclerosis. Neuroimage Clin. 2016;11:408&#x2013;414. doi: 10.1016/j.nicl.2016.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.03.011</ArticleId><ArticleId IdType="pmc">PMC4827722</ArticleId><ArticleId IdType="pubmed">27104135</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Eijk R.P.A., Kliest T., van den Berg L.H. Current Trends in the Clinical Trial Landscape for Amyotrophic Lateral Sclerosis. Curr. Opin. Neurol. 2020;33:655&#x2013;661. doi: 10.1097/WCO.0000000000000861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000861</ArticleId><ArticleId IdType="pubmed">32796282</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P., Huss A., Mayer B., Grehl T., Grosskreutz J., Borck G., Kuhle J., Lul&#xe9; D., Meyer T., Oeckl P., et al. Diagnostic and Prognostic Significance of Neurofilament Light Chain NF-L, but Not Progranulin and S100B, in the Course of Amyotrophic Lateral Sclerosis: Data from the German MND-Net. Amyotroph. Lateral Scler. Front. Degener. 2017;18:112&#x2013;119. doi: 10.1080/21678421.2016.1241279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1241279</ArticleId><ArticleId IdType="pubmed">27819158</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster B.R., Dwamena B.A., Petrou M., Carlos R.C., Callaghan B.C., Pomper M.G. Diagnostic Accuracy Using Diffusion Tensor Imaging in the Diagnosis of ALS: A Meta-Analysis. Acad. Radiol. 2012;19:1075&#x2013;1086. doi: 10.1016/j.acra.2012.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acra.2012.04.012</ArticleId><ArticleId IdType="pmc">PMC4337857</ArticleId><ArticleId IdType="pubmed">22749050</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F., Stecco A., Falaschi Z., Filippone F., Pasch&#xe9; A., Bebeti A., Leigheb M., Cantello R., Mazzini L. Detection of White Matter Ultrastructural Changes for Amyotrophic Lateral Sclerosis Characterization: A Diagnostic Study from Dti-Derived Data. Brain Sci. 2020;10:996. doi: 10.3390/brainsci10120996.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10120996</ArticleId><ArticleId IdType="pmc">PMC7766961</ArticleId><ArticleId IdType="pubmed">33339434</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahedl M., Murad A., Lope J., Hardiman O., Bede P. Evaluation and Categorisation of Individual Patients Based on White Matter Profiles: Single-Patient Diffusion Data Interpretation in Neurodegeneration. J. Neurol. Sci. 2021;428:117584. doi: 10.1016/j.jns.2021.117584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117584</ArticleId><ArticleId IdType="pubmed">34315000</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu K.-H., Beam A.L., Kohane I.S. Artificial Intelligence in Healthcare. Nat. Biomed. Eng. 2018;2:719&#x2013;731. doi: 10.1038/s41551-018-0305-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-018-0305-z</ArticleId><ArticleId IdType="pubmed">31015651</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund V., Pradat P.-F., Querin G., Delbot F., Le Chat G., Pradat-Peyre J.-F., Bede P. Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions. Front. Neurosci. 2019;13:135. doi: 10.3389/fnins.2019.00135.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00135</ArticleId><ArticleId IdType="pmc">PMC6403867</ArticleId><ArticleId IdType="pubmed">30872992</ArticleId></ArticleIdList></Reference><Reference><Citation>Davatzikos C. Machine Learning in Neuroimaging: Progress and Challenges. Neuroimage. 2019;197:652&#x2013;656. doi: 10.1016/j.neuroimage.2018.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2018.10.003</ArticleId><ArticleId IdType="pmc">PMC6499712</ArticleId><ArticleId IdType="pubmed">30296563</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr&#xf9; G., Pettersson-Yeo W., Marquand A.F., Sartori G., Mechelli A. Using Support Vector Machine to Identify Imaging Biomarkers of Neurological and Psychiatric Disease: A Critical Review. Neurosci. Biobehav. Rev. 2012;36:1140&#x2013;1152. doi: 10.1016/j.neubiorev.2012.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2012.01.004</ArticleId><ArticleId IdType="pubmed">22305994</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarica A., Cerasa A., Quattrone A. Random Forest Algorithm for the Classification of Neuroimaging Data in Alzheimer&#x2019;s Disease: A Systematic Review. Front. Aging Neurosci. 2017;9:329. doi: 10.3389/fnagi.2017.00329.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00329</ArticleId><ArticleId IdType="pmc">PMC5635046</ArticleId><ArticleId IdType="pubmed">29056906</ArticleId></ArticleIdList></Reference><Reference><Citation>Raudys &#x160;. Statistical and Neural Classifiers. Springer London; London, UK: 2001. Advances in Pattern Recognition.</Citation></Reference><Reference><Citation>Chen Q.-F., Zhang X.-H., Huang N.-X., Chen H.-J. Identification of Amyotrophic Lateral Sclerosis Based on Diffusion Tensor Imaging and Support Vector Machine. Front. Neurol. 2020;11:275. doi: 10.3389/fneur.2020.00275.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00275</ArticleId><ArticleId IdType="pmc">PMC7198809</ArticleId><ArticleId IdType="pubmed">32411072</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarica A., Cerasa A., Valentino P., Yeatman J., Trotta M., Barone S., Granata A., Nistic&#xf2; R., Perrotta P., Pucci F., et al. The Corticospinal Tract Profile in Amyotrophic Lateral Sclerosis. Hum. Brain Mapp. 2017;38:727&#x2013;739. doi: 10.1002/hbm.23412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.23412</ArticleId><ArticleId IdType="pmc">PMC6867092</ArticleId><ArticleId IdType="pubmed">27659483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraro P.M., Agosta F., Riva N., Copetti M., Spinelli E.G., Falzone Y., Sorar&#xf9; G., Comi G., Chi&#xf2; A., Filippi M. Multimodal Structural MRI in the Diagnosis of Motor Neuron Diseases. Neuroimage Clin. 2017;16:240&#x2013;247. doi: 10.1016/j.nicl.2017.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.08.002</ArticleId><ArticleId IdType="pmc">PMC5545829</ArticleId><ArticleId IdType="pubmed">28794983</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocar T.D., Behler A., Ludolph A.C., M&#xfc;ller H.-P., Kassubek J. Multiparametric Microstructural MRI and Machine Learning Classification Yields High Diagnostic Accuracy in Amyotrophic Lateral Sclerosis: Proof of Concept. Front. Neurol. 2021;12:745475. doi: 10.3389/fneur.2021.745475.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.745475</ArticleId><ArticleId IdType="pmc">PMC8637840</ArticleId><ArticleId IdType="pubmed">34867726</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan H.H.G., Westeneng H., Nitert A.D., van Veenhuijzen K., Meier J.M., van der Burgh H.K., van Zandvoort M.J.E., van Es M.A., Veldink J.H., van den Berg L.H. MRI Clustering Reveals Three ALS Subtypes With Unique Neurodegeneration Patterns. Ann. Neurol. 2022;92:ana.26488. doi: 10.1002/ana.26488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26488</ArticleId><ArticleId IdType="pmc">PMC9826424</ArticleId><ArticleId IdType="pubmed">36054734</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Wei Q., Hou Y., Lei D., Yuan A., Yuan A., Ai Y., Qin K., Yang J., Yang J., et al. Disruption of the White Matter Structural Network and Its Correlation with Baseline Progression Rate in Patients with Sporadic Amyotrophic Lateral Sclerosis. Transl. Neurodegener. 2021;10:35. doi: 10.1186/s40035-021-00255-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00255-0</ArticleId><ArticleId IdType="pmc">PMC8436442</ArticleId><ArticleId IdType="pubmed">34511130</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratello M., Caiazzo G., Trojsi F., Russo A., Tedeschi G., Tagliaferri R., Esposito F. Multi-View Ensemble Classification of Brain Connectivity Images for Neurodegeneration Type Discrimination. Neuroinform. 2017;15:199&#x2013;213. doi: 10.1007/s12021-017-9324-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12021-017-9324-2</ArticleId><ArticleId IdType="pmc">PMC5443864</ArticleId><ArticleId IdType="pubmed">28210983</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabel M.C., Broad R.J., Young A.L., Abrahams S., Bastin M.E., Menke R.A.L., Al-Chalabi A., Goldstein L.H., Tsermentseli S., Alexander D.C., et al. Evolution of White Matter Damage in Amyotrophic Lateral Sclerosis. Ann. Clin. Transl. Neurol. 2020;7:722&#x2013;732. doi: 10.1002/acn3.51035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51035</ArticleId><ArticleId IdType="pmc">PMC7261765</ArticleId><ArticleId IdType="pubmed">32367696</ArticleId></ArticleIdList></Reference><Reference><Citation>Behler A., M&#xfc;ller H.-P., Ludolph A.C., Lul&#xe9; D., Kassubek J. A Multivariate Bayesian Classification Algorithm for Cerebral Stage Prediction by Diffusion Tensor Imaging in Amyotrophic Lateral Sclerosis. Neuroimage Clin. 2022;35:103094. doi: 10.1016/j.nicl.2022.103094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2022.103094</ArticleId><ArticleId IdType="pmc">PMC9253469</ArticleId><ArticleId IdType="pubmed">35772192</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Murad A., Hardiman O. Pathological Neural Networks and Artificial Neural Networks in ALS: Diagnostic Classification Based on Pathognomonic Neuroimaging Features. J. Neurol. 2022;269:2440&#x2013;2452. doi: 10.1007/s00415-021-10801-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10801-5</ArticleId><ArticleId IdType="pmc">PMC9021106</ArticleId><ArticleId IdType="pubmed">34585269</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Tredici K., Braak H. Neuropathology and Neuroanatomy of TDP-43 Amyotrophic Lateral Sclerosis. Curr. Opin. Neurol. 2022;35:660&#x2013;671. doi: 10.1097/WCO.0000000000001098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000001098</ArticleId><ArticleId IdType="pubmed">36069419</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsh R.C., Jelsone-Swain L., Foerster B.R. The Utility of Independent Component Analysis and Machine Learning in the Identification of the Amyotrophic Lateral Sclerosis Diseased Brain. Front. Hum. Neurosci. 2013;7:251. doi: 10.3389/fnhum.2013.00251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2013.00251</ArticleId><ArticleId IdType="pmc">PMC3677153</ArticleId><ArticleId IdType="pubmed">23772210</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Iyer P.M., Finegan E., Omer T., Hardiman O. Virtual Brain Biopsies in Amyotrophic Lateral Sclerosis: Diagnostic Classification Based on In Vivo Pathological Patterns. Neuroimage Clin. 2017;15:653&#x2013;658. doi: 10.1016/j.nicl.2017.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2017.06.010</ArticleId><ArticleId IdType="pmc">PMC5479963</ArticleId><ArticleId IdType="pubmed">28664036</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C., Hardiman O., Bede P. Development of an Automated MRI-Based Diagnostic Protocol for Amyotrophic Lateral Sclerosis Using Disease-Specific Pathognomonic Features: A Quantitative Disease-State Classification Study. PLoS ONE. 2016;11:e0167331. doi: 10.1371/journal.pone.0167331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0167331</ArticleId><ArticleId IdType="pmc">PMC5132189</ArticleId><ArticleId IdType="pubmed">27907080</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Burgh H.K., Schmidt R., Westeneng H.-J., de Reus M.A., van den Berg L.H., van den Heuvel M.P. Deep Learning Predictions of Survival Based on MRI in Amyotrophic Lateral Sclerosis. NeuroImage Clin. 2017;13:361&#x2013;369. doi: 10.1016/j.nicl.2016.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.10.008</ArticleId><ArticleId IdType="pmc">PMC5219634</ArticleId><ArticleId IdType="pubmed">28070484</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth A.M., Khomenko A., Baldaranov D., Kobor I., Hsam O., Grimm T., Johannesen S., Bruun T.-H., Schulte-Mattler W., Greenlee M.W., et al. Combinatory Biomarker Use of Cortical Thickness, MUNIX, and ALSFRS-R at Baseline and in Longitudinal Courses of Individual Patients With Amyotrophic Lateral Sclerosis. Front. Neurol. 2018;9:614. doi: 10.3389/fneur.2018.00614.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00614</ArticleId><ArticleId IdType="pmc">PMC6077217</ArticleId><ArticleId IdType="pubmed">30104996</ArticleId></ArticleIdList></Reference><Reference><Citation>Behler A., M&#xfc;ller H., Del Tredici K., Braak H., Ludolph A.C., Lul&#xe9; D., Kassubek J. Multimodal in Vivo Staging in Amyotrophic Lateral Sclerosis Using Artificial Intelligence. Ann. Clin. Transl. Neurol. 2022;9:1069&#x2013;1079. doi: 10.1002/acn3.51601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51601</ArticleId><ArticleId IdType="pmc">PMC9268886</ArticleId><ArticleId IdType="pubmed">35684940</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C., Hardiman O., Bede P. Survival Prediction in Amyotrophic Lateral Sclerosis Based on MRI Measures and Clinical Characteristics. BMC Neurol. 2017;17:73. doi: 10.1186/s12883-017-0854-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-017-0854-x</ArticleId><ArticleId IdType="pmc">PMC5393027</ArticleId><ArticleId IdType="pubmed">28412941</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Elamin M., Byrne S., Hardiman O. Sexual Dimorphism in ALS: Exploring Gender-Specific Neuroimaging Signatures. Amyotroph. Lateral Scler. Front. Degener. 2014;15:235&#x2013;243. doi: 10.3109/21678421.2013.865749.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.865749</ArticleId><ArticleId IdType="pubmed">24344910</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbabshirani M.R., Plis S., Sui J., Calhoun V.D. Single Subject Prediction of Brain Disorders in Neuroimaging: Promises and Pitfalls. NeuroImage. 2017;145:137&#x2013;165. doi: 10.1016/j.neuroimage.2016.02.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2016.02.079</ArticleId><ArticleId IdType="pmc">PMC5031516</ArticleId><ArticleId IdType="pubmed">27012503</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial Revisited: Revised Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannaford A., Pavey N., Bos M., Geevasinga N., Menon P., Shefner J.M., Kiernan M.C., Vucic S. Diagnostic Utility of Gold Coast Criteria in Amyotrophic Lateral Sclerosis. Ann. Neurol. 2021;89:979&#x2013;986. doi: 10.1002/ana.26045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26045</ArticleId><ArticleId IdType="pubmed">33565111</ArticleId></ArticleIdList></Reference><Reference><Citation>De Jongh A.D., Braun N., Weber M., van Es M.A., Masrori P., Veldink J.H., van Damme P., van den Berg L.H., van Eijk R.P.A. Characterising ALS Disease Progression According to El Escorial and Gold Coast Criteria. J Neurol Neurosurg Psychiatry. 2022;93:865&#x2013;870. doi: 10.1136/jnnp-2022-328823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2022-328823</ArticleId><ArticleId IdType="pubmed">35654584</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynor B.J., Codd M.B., Corr B., Forde C., Frost E., Hardiman O. Amyotrophic Lateral Sclerosis Mimic Syndromes: A Population-Based Study. Arch. Neurol. 2000;57:109. doi: 10.1001/archneur.57.1.109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.57.1.109</ArticleId><ArticleId IdType="pubmed">10634456</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A., Drory V., Hardiman O., Nakano I., Ravits J., Robberecht W., Shefner J. For The WFN Research Group On ALS/MND A Revision of the El Escorial Criteria&#x2014;2015. Amyotroph. Lateral Scler. Front. Degener. 2015;16:291&#x2013;292. doi: 10.3109/21678421.2015.1049183.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vries B.S., Rustemeijer L.M.M., Bakker L.A., Schr&#xf6;der C.D., Veldink J.H., van den Berg L.H., Nijboer T.C.W., van Es M.A. Cognitive and Behavioural Changes in PLS and PMA:Challenging the Concept of Restricted Phenotypes. J. Neurol. Neurosurg. Psychiatry. 2019;90:141&#x2013;147. doi: 10.1136/jnnp-2018-318788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318788</ArticleId><ArticleId IdType="pubmed">30076267</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E., Chipika R.H., Shing S.L.H., Hardiman O., Bede P. Primary Lateral Sclerosis: A Distinct Entity or Part of the ALS Spectrum? Amyotroph. Lateral Scler. Front. Degener. 2019;20:133&#x2013;145. doi: 10.1080/21678421.2018.1550518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1550518</ArticleId><ArticleId IdType="pubmed">30654671</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J., M&#xfc;ller H.-P. Advanced Neuroimaging Approaches in Amyotrophic Lateral Sclerosis: Refining the Clinical Diagnosis. Expert Rev. Neurother. 2020;20:237&#x2013;249. doi: 10.1080/14737175.2020.1715798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2020.1715798</ArticleId><ArticleId IdType="pubmed">31937156</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbohm A., Del Tredici K., Braak H., Huppertz H.-J., Ludolph A.C., M&#xfc;ller H.-P., Kassubek J. Involvement of Cortico-Efferent Tracts in Flail Arm Syndrome: A Tract-of-Interest-Based DTI Study. J. Neurol. 2022;269:2619&#x2013;2626. doi: 10.1007/s00415-021-10854-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10854-6</ArticleId><ArticleId IdType="pmc">PMC9021061</ArticleId><ArticleId IdType="pubmed">34676447</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarica A., Valentino P., Nistic&#xf2; R., Barone S., Pucci F., Quattrone A., Cerasa A., Quattrone A. Assessment of the Corticospinal Tract Profile in Pure Lower Motor Neuron Disease: A Diffusion Tensor Imaging Study. Neurodegener Dis. 2019;19:128&#x2013;138. doi: 10.1159/000503970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000503970</ArticleId><ArticleId IdType="pubmed">31715609</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch M., M&#xfc;ller H.-P., Behler A., Ludolph A.C., Kassubek J. Segmental Alterations of the Corpus Callosum in Motor Neuron Disease: A DTI and Texture Analysis in 575 Patients. Neuroimage Clin. 2022;35:103061. doi: 10.1016/j.nicl.2022.103061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2022.103061</ArticleId><ArticleId IdType="pmc">PMC9163839</ArticleId><ArticleId IdType="pubmed">35653913</ArticleId></ArticleIdList></Reference><Reference><Citation>Temp A.G.M., Naumann M., Hermann A., Gla&#xdf; H. Applied Bayesian Approaches for Research in Motor Neuron Disease. Front. Neurol. 2022;13:796777. doi: 10.3389/fneur.2022.796777.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.796777</ArticleId><ArticleId IdType="pmc">PMC8987707</ArticleId><ArticleId IdType="pubmed">35401404</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromicho M., Le&#xe3;o T., Oliveira Santos M., Pinto S., Carvalho A.M., Madeira S.C., De Carvalho M. Dynamic Bayesian Networks for Stratification of Disease Progression in Amyotrophic Lateral Sclerosis. Eur. J. Neurol. 2022;29:2201&#x2013;2210. doi: 10.1111/ene.15357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15357</ArticleId><ArticleId IdType="pubmed">35426195</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek S.-H., Park J., Kim Y.H., Seok H.Y., Oh K.-W., Kim H.-J., Kwon Y.-J., Sim Y., Tae W.-S., Kim S.H., et al. Usefulness of Diffusion Tensor Imaging Findings as Biomarkers for Amyotrophic Lateral Sclerosis. Sci. Rep. 2020;10:5199. doi: 10.1038/s41598-020-62049-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62049-0</ArticleId><ArticleId IdType="pmc">PMC7090054</ArticleId><ArticleId IdType="pubmed">32251314</ArticleId></ArticleIdList></Reference><Reference><Citation>Alruwaili A.R., Pannek K., Henderson R.D., Gray M., Kurniawan N.D., McCombe P.A. Tract Integrity in Amyotrophic Lateral Sclerosis: 6&#x2013;Month Evaluation Using MR Diffusion Tensor Imaging. BMC Med. Imaging. 2019;19:19. doi: 10.1186/s12880-019-0319-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12880-019-0319-3</ArticleId><ArticleId IdType="pmc">PMC6387547</ArticleId><ArticleId IdType="pubmed">30795741</ArticleId></ArticleIdList></Reference><Reference><Citation>Blain C.R.V., Williams V.C., Johnston C., Stanton B.R., Ganesalingam J., Jarosz J.M., Jones D.K., Barker G.J., Williams S.C.R., Leigh N.P., et al. A Longitudinal Study of Diffusion Tensor MRI in ALS. Amyotroph. Lateral. Scler. 2007;8:348&#x2013;355. doi: 10.1080/17482960701548139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701548139</ArticleId><ArticleId IdType="pubmed">17924235</ArticleId></ArticleIdList></Reference><Reference><Citation>Distaso E., Milella G., Mezzapesa D.M., Introna A., D&#x2019;Errico E., Fraddosio A., Zoccolella S., Dicuonzo F., Simone I.L. Magnetic Resonance Metrics to Evaluate the Effect of Therapy in Amyotrophic Lateral Sclerosis: The Experience with Edaravone. J. Neurol. 2021;268:3307&#x2013;3315. doi: 10.1007/s00415-021-10495-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10495-9</ArticleId><ArticleId IdType="pmc">PMC8357666</ArticleId><ArticleId IdType="pubmed">33655342</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Schuff N., Woolley S.C., Chiang G.C., Boreta L., Laxamana J., Katz J.S., Weiner M.W. Progression of White Matter Degeneration in Amyotrophic Lateral Sclerosis: A Diffusion Tensor Imaging Study. Amyotroph. Lateral Scler. 2011;12:421&#x2013;429. doi: 10.3109/17482968.2011.593036.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.593036</ArticleId><ArticleId IdType="pmc">PMC3804304</ArticleId><ArticleId IdType="pubmed">21745124</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Hedo R., Rivera A., Rull R., Richardson S., Tu X.M. Post Hoc Power Analysis: Is It an Informative and Meaningful Analysis? Gen. Psychiatry. 2019;32:e100069. doi: 10.1136/gpsych-2019-100069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gpsych-2019-100069</ArticleId><ArticleId IdType="pmc">PMC6738696</ArticleId><ArticleId IdType="pubmed">31552383</ArticleId></ArticleIdList></Reference><Reference><Citation>Behler A., Lul&#xe9; D., Ludolph A.C., Kassubek J., M&#xfc;ller H.-P. Longitudinal Monitoring of Amyotrophic Lateral Sclerosis by Diffusion Tensor Imaging: Power Calculations for Group Studies. Front. Neurosci. 2022;16:929151. doi: 10.3389/fnins.2022.929151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.929151</ArticleId><ArticleId IdType="pmc">PMC9479493</ArticleId><ArticleId IdType="pubmed">36117627</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller H.-P., Behler A., Landwehrmeyer G.B., Huppertz H.-J., Kassubek J. How to Arrange Follow-Up Time-Intervals for Longitudinal Brain MRI Studies in Neurodegenerative Diseases. Front. Neurosci. 2021;15:682812. doi: 10.3389/fnins.2021.682812.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.682812</ArticleId><ArticleId IdType="pmc">PMC8319674</ArticleId><ArticleId IdType="pubmed">34335162</ArticleId></ArticleIdList></Reference><Reference><Citation>Westlye L.T., Walhovd K.B., Dale A.M., Bj&#xf8;rnerud A., Due-T&#xf8;nnessen P., Engvig A., Grydeland H., Tamnes C.K., Ostby Y., Fjell A.M. Life-Span Changes of the Human Brain White Matter: Diffusion Tensor Imaging (DTI) and Volumetry. Cereb. Cortex. 2010;20:2055&#x2013;2068. doi: 10.1093/cercor/bhp280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhp280</ArticleId><ArticleId IdType="pubmed">20032062</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox S.R., Ritchie S.J., Tucker-Drob E.M., Liewald D.C., Hagenaars S.P., Davies G., Wardlaw J.M., Gale C.R., Bastin M.E., Deary I.J. Ageing and Brain White Matter Structure in 3,513 UK Biobank Participants. Nat. Commun. 2016;7:13629. doi: 10.1038/ncomms13629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13629</ArticleId><ArticleId IdType="pmc">PMC5172385</ArticleId><ArticleId IdType="pubmed">27976682</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra S., M&#xfc;ller H.-P., Ishaque A., Zinman L., Korngut L., Genge A., Beaulieu C., Frayne R., Graham S.J., Kassubek J. A Prospective Harmonized Multicenter DTI Study of Cerebral White Matter Degeneration in ALS. Neurology. 2020;95:e943&#x2013;e952. doi: 10.1212/WNL.0000000000010235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010235</ArticleId><ArticleId IdType="pmc">PMC7668555</ArticleId><ArticleId IdType="pubmed">32646955</ArticleId></ArticleIdList></Reference><Reference><Citation>Behler A., Kassubek J., M&#xfc;ller H.-P. Age-Related Alterations in DTI Metrics in the Human Brain&#x2014;Consequences for Age Correction. Front. Aging Neurosci. 2021;13:682109. doi: 10.3389/fnagi.2021.682109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.682109</ArticleId><ArticleId IdType="pmc">PMC8239142</ArticleId><ArticleId IdType="pubmed">34211389</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke K., Gaser C. Ten Years of BrainAGE as a Neuroimaging Biomarker of Brain Aging: What Insights Have We Gained? Front. Neurol. 2019;10:789. doi: 10.3389/fneur.2019.00789.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00789</ArticleId><ArticleId IdType="pmc">PMC6702897</ArticleId><ArticleId IdType="pubmed">31474922</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole J.H., Franke K. Predicting Age Using Neuroimaging: Innovative Brain Ageing Biomarkers. Trends Neurosci. 2017;40:681&#x2013;690. doi: 10.1016/j.tins.2017.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2017.10.001</ArticleId><ArticleId IdType="pubmed">29074032</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole J.H. Multimodality Neuroimaging Brain-Age in UK Biobank: Relationship to Biomedical, Lifestyle, and Cognitive Factors. Neurobiol. Aging. 2020;92:34&#x2013;42. doi: 10.1016/j.neurobiolaging.2020.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2020.03.014</ArticleId><ArticleId IdType="pmc">PMC7280786</ArticleId><ArticleId IdType="pubmed">32380363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocar T.D., Behler A., Leinert C., Denkinger M., Ludolph A.C., M&#xfc;ller H.-P., Kassubek J. Artificial Neural Networks for Non-Linear Age Correction of Diffusion Metrics in the Brain. Front. Aging Neurosci. 2022;14:999787. doi: 10.3389/fnagi.2022.999787.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.999787</ArticleId><ArticleId IdType="pmc">PMC9632350</ArticleId><ArticleId IdType="pubmed">36337697</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F., Ingre C., Roos P., Kamel F., Piehl F. Risk Factors for Amyotrophic Lateral Sclerosis. CLEP. 2015;7:181. doi: 10.2147/CLEP.S37505.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S37505</ArticleId><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermann A., Tarakdjian G.N., Temp A.G.M., Kasper E., Machts J., Kaufmann J., Vielhaber S., Prudlo J., Cole J.H., Teipel S., et al. Cognitive and Behavioural but Not Motor Impairment Increases Brain Age in Amyotrophic Lateral Sclerosis. Brain Commun. 2022;4:fcac239. doi: 10.1093/braincomms/fcac239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcac239</ArticleId><ArticleId IdType="pmc">PMC9556938</ArticleId><ArticleId IdType="pubmed">36246047</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke K., Ristow M., Gaser C. Gender-Specific Impact of Personal Health Parameters on Individual Brain Aging in Cognitively Unimpaired Elderly Subjects. Front. Aging Neurosci. 2014;6:94. doi: 10.3389/fnagi.2014.00094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00094</ArticleId><ArticleId IdType="pmc">PMC4033192</ArticleId><ArticleId IdType="pubmed">24904408</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck D., de Lange A.-M.G., Aln&#xe6;s D., Maximov I.I., Pedersen M.L., Leinhard O.D., Linge J., Simon R., Richard G., Ulrichsen K.M., et al. Adipose Tissue Distribution from Body MRI Is Associated with Cross-Sectional and Longitudinal Brain Age in Adults. NeuroImage Clin. 2022;33:102949. doi: 10.1016/j.nicl.2022.102949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2022.102949</ArticleId><ArticleId IdType="pmc">PMC8814666</ArticleId><ArticleId IdType="pubmed">35114636</ArticleId></ArticleIdList></Reference><Reference><Citation>McEvoy L.K., Fennema-Notestine C., Elman J.A., Eyler L.T., Franz C.E., Hagler D.J., Hatton S.N., Lyons M.J., Panizzon M.S., Dale A.M., et al. Alcohol Intake and Brain White Matter in Middle Aged Men: Microscopic and Macroscopic Differences. NeuroImage Clin. 2018;18:390&#x2013;398. doi: 10.1016/j.nicl.2018.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.02.006</ArticleId><ArticleId IdType="pmc">PMC5816025</ArticleId><ArticleId IdType="pubmed">29487796</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Xu X., Qian W., Shen Z., Zhang M. Altered Human Brain Anatomy in Chronic Smokers: A Review of Magnetic Resonance Imaging Studies. Neurol. Sci. 2015;36:497&#x2013;504. doi: 10.1007/s10072-015-2065-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-015-2065-9</ArticleId><ArticleId IdType="pubmed">25577510</ArticleId></ArticleIdList></Reference><Reference><Citation>Topiwala A., Allan C.L., Valkanova V., Zsoldos E., Filippini N., Sexton C., Mahmood A., Fooks P., Singh-Manoux A., Mackay C.E., et al. Moderate Alcohol Consumption as Risk Factor for Adverse Brain Outcomes and Cognitive Decline: Longitudinal Cohort Study. BMJ. 2017;357:j2353. doi: 10.1136/bmj.j2353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j2353</ArticleId><ArticleId IdType="pmc">PMC5460586</ArticleId><ArticleId IdType="pubmed">28588063</ArticleId></ArticleIdList></Reference><Reference><Citation>Grumbach P., Opel N., Martin S., Meinert S., Leehr E.J., Redlich R., Enneking V., Goltermann J., Baune B.T., Dannlowski U., et al. Sleep Duration Is Associated with White Matter Microstructure and Cognitive Performance in Healthy Adults. Hum. Brain Mapp. 2020;41:4397&#x2013;4405. doi: 10.1002/hbm.25132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.25132</ArticleId><ArticleId IdType="pmc">PMC7502839</ArticleId><ArticleId IdType="pubmed">32648625</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalmaijer E.S., Nord C.L., Astle D.E. Statistical Power for Cluster Analysis. BMC Bioinform. 2022;23:205. doi: 10.1186/s12859-022-04675-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-022-04675-1</ArticleId><ArticleId IdType="pmc">PMC9158113</ArticleId><ArticleId IdType="pubmed">35641905</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinaya W.H.L., Scarpazza C., Garcia-Dias R., Vieira S., Baecker L., F da Costa P., Redolfi A., Frisoni G.B., Pievani M., Calhoun V.D., et al. Using Normative Modelling to Detect Disease Progression in Mild Cognitive Impairment and Alzheimer&#x2019;s Disease in a Cross-Sectional Multi-Cohort Study. Sci. Rep. 2021;11:15746. doi: 10.1038/s41598-021-95098-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95098-0</ArticleId><ArticleId IdType="pmc">PMC8333350</ArticleId><ArticleId IdType="pubmed">34344910</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi M., Agosta F., Grosskreutz J., Benatar M., Kassubek J., Verstraete E., Turner M.R. Progress towards a Neuroimaging Biomarker for Amyotrophic Lateral Sclerosis. Lancet Neurol. 2015;14:786&#x2013;788. doi: 10.1016/S1474-4422(15)00134-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)00134-9</ArticleId><ArticleId IdType="pubmed">26194923</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach R., Gaur N., Stubendorff B., Witte O.W., Grosskreutz J. Developing a Neuroimaging Biomarker for Amyotrophic Lateral Sclerosis: Multi-Center Data Sharing and the Road to a &#x201c;Global Cohort&#x201d;. Front. Neurol. 2018;9:1055. doi: 10.3389/fneur.2018.01055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01055</ArticleId><ArticleId IdType="pmc">PMC6288231</ArticleId><ArticleId IdType="pubmed">30564187</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto M.S., Paolella R., Billiet T., Van Dyck P., Guns P.-J., Jeurissen B., Ribbens A., den Dekker A.J., Sijbers J. Harmonization of Brain Diffusion MRI: Concepts and Methods. Front. Neurosci. 2020;14:396. doi: 10.3389/fnins.2020.00396.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00396</ArticleId><ArticleId IdType="pmc">PMC7218137</ArticleId><ArticleId IdType="pubmed">32435181</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaharchuk G., Gong E., Wintermark M., Rubin D., Langlotz C.P. Deep Learning in Neuroradiology. Am. J. Neuroradiol. 2018;39:1776&#x2013;1784. doi: 10.3174/ajnr.A5543.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A5543</ArticleId><ArticleId IdType="pmc">PMC7410723</ArticleId><ArticleId IdType="pubmed">29419402</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Tang L., Majety A., Rousseau J.F., Shih G., Ding Y., Peng Y. Trustworthy Assertion Classification through Prompting. J. Biomed. Inform. 2022;132:104139. doi: 10.1016/j.jbi.2022.104139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2022.104139</ArticleId><ArticleId IdType="pmc">PMC9378721</ArticleId><ArticleId IdType="pubmed">35811026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamagata K., Andica C., Kato A., Saito Y., Uchida W., Hatano T., Lukies M., Ogawa T., Takeshige-Amano H., Akashi T., et al. Diffusion Magnetic Resonance Imaging-Based Biomarkers for Neurodegenerative Diseases. IJMS. 2021;22:5216. doi: 10.3390/ijms22105216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22105216</ArticleId><ArticleId IdType="pmc">PMC8155849</ArticleId><ArticleId IdType="pubmed">34069159</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.-J., Zhan C., Cai L.-M., Lin J.-H., Zhou M.-X., Zou Z.-Y., Yao X.-F., Lin Y.-J. White Matter Microstructural Impairments in Amyotrophic Lateral Sclerosis: A Mean Apparent Propagator MRI Study. NeuroImage Clin. 2021;32:102863. doi: 10.1016/j.nicl.2021.102863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2021.102863</ArticleId><ArticleId IdType="pmc">PMC8551695</ArticleId><ArticleId IdType="pubmed">34700102</ArticleId></ArticleIdList></Reference><Reference><Citation>Welton T., Maller J.J., Lebel R.M., Tan E.T., Rowe D.B., Grieve S.M. Diffusion Kurtosis and Quantitative Susceptibility Mapping MRI Are Sensitive to Structural Abnormalities in Amyotrophic Lateral Sclerosis. NeuroImage Clin. 2019;24:101953. doi: 10.1016/j.nicl.2019.101953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.101953</ArticleId><ArticleId IdType="pmc">PMC6664242</ArticleId><ArticleId IdType="pubmed">31357149</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang N., Zou Z., Xue Y., Chen H. Abnormal Cerebral Microstructures Revealed by Diffusion Kurtosis Imaging in Amyotrophic Lateral Sclerosis. J. Magn. Reson. Imaging. 2020;51:554&#x2013;562. doi: 10.1002/jmri.26843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.26843</ArticleId><ArticleId IdType="pubmed">31206873</ArticleId></ArticleIdList></Reference><Reference><Citation>Juengling F.D., Wuest F., Kalra S., Agosta F., Schirrmacher R., Thiel A., Thaiss W., M&#xfc;ller H.-P., Kassubek J. Simultaneous PET/MRI: The Future Gold Standard for Characterizing Motor Neuron Disease&#x2014;A Clinico-Radiological and Neuroscientific Perspective. Front. Neurol. 2022;13:890425. doi: 10.3389/fneur.2022.890425.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.890425</ArticleId><ArticleId IdType="pmc">PMC9428135</ArticleId><ArticleId IdType="pubmed">36061999</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;bers A., Kassubek J., M&#xfc;ller H.-P., Broc N., Dreyhaupt J., Ludolph A.C. The Ipsilateral Silent Period: An Early Diagnostic Marker of Callosal Disconnection in ALS. Ther. Adv. Chronic Dis. 2021;12:20406223211044070. doi: 10.1177/20406223211044072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223211044072</ArticleId><ArticleId IdType="pmc">PMC8442475</ArticleId><ArticleId IdType="pubmed">34729145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan M.C., Vucic S., Talbot K., McDermott C.J., Hardiman O., Shefner J.M., Al-Chalabi A., Huynh W., Cudkowicz M., Talman P., et al. Improving Clinical Trial Outcomes in Amyotrophic Lateral Sclerosis. Nat. Rev. Neurol. 2021;17:104&#x2013;118. doi: 10.1038/s41582-020-00434-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00434-z</ArticleId><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>